Ausgabe 5/2011
Inhalt (15 Artikel)
The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model
Tamar Tadmor, Yu Zhang, Hyun-Mi Cho, Eckhard R. Podack, Joseph D. Rosenblatt
Impact of minimal tumor burden on antibody response to vaccination
Soo-Kie Kim, Xiaohong Wu, Govind Ragupathi, John Gathuru, Fusataka Koide, Nai-Kong Cheung, Katherine Panageas, Philip O. Livingston
Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine
Elizabeth A. Vasievich, Weihsu Chen, Leaf Huang
Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC
Christina Battke, Romana Ruiss, Ulrich Welsch, Pauline Wimberger, Stephan Lang, Simon Jochum, Reinhard Zeidler
Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII
Christina Battke, Elisabeth Kremmer, Josef Mysliwietz, Gabor Gondi, Claudia Dumitru, Sven Brandau, Stephan Lang, Daniela Vullo, Claudiu Supuran, Reinhard Zeidler
CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunity
Hidekazu Shirota, Dennis M. Klinman
Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice
Sally M. Amos, Hollie J. Pegram, Jennifer A. Westwood, Liza B. John, Christel Devaud, Chris J. Clarke, Nicholas P. Restifo, Mark J. Smyth, Phillip K. Darcy, Michael H. Kershaw
Molecular analysis of melanoma-induced sentinel lymph node immune dysfunction
Jonathan H. Lee, Yun Chen, Joseph L. Chan, You-wen Qian, James S. Goydos
TH1 predominance is associated with improved survival in pediatric medulloblastoma patients
Verena Wiegering, Matthias Eyrich, Stefan Rutkowski, Matthias Wölfl, Paul G. Schlegel, Beate Winkler
An engineered superantigen SEC2 exhibits promising antitumor activity and low toxicity
Mingkai Xu, Xiaogang Wang, Yongming Cai, Huiwen Zhang, Hongli Yang, Changxiao Liu, Chenggang Zhang
Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer
Qiushan He, Jinlong Li, Weihua Yin, Zhichun Song, Zhen Zhang, Tienan Yi, Jia Tang, Demin Wu, Yue Lu, Zhen Wang, Dan Liu, Xiaoren Zhang, Zhiming Hu, Jimin Gao
The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model
Brenda L. Soto, Jacquelyn A. Hank, Tyler J. Van De Voort, Lalita Subramanian, Arthur S. Polans, Alexander L. Rakhmilevich, Richard K. Yang, Songwong Seo, KyungMann Kim, Ralph A. Reisfeld, Stephen D. Gillies, Paul M. Sondel
In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells
Shicheng Yang, Gattinoni Luca, Fang Liu, Yun Ji, Zhiya Yu, Nicholas P. Restifo, Steven A. Rosenberg, Richard A. Morgan
Erratum to: In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells
Shicheng Yang, Luca Gattinoni, Fang Liu, Yun Ji, Zhiya Yu, Nicholas P. Restifo, Steven A. Rosenberg, Richard A. Morgan
International symposium on CTL and immunostimulation, Pamplona (Spain), October 26th and 27th 2010
Maria C. Ochoa, Sandra Hervas-Stubbs, Asis Palazon, Ivan Martinez-Forero, Pedro Berraondo, Pablo Sarobe, Alan Melcher, Ignacio Melero